Brandinium

Trademark search for:

SANCILIO PHARMACEUTICALS COMPANY, INC.

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2015-08-24 — Application filed
  • 2015-08-27 — Application filed
  • 2015-08-27 — Application filed
  • 2015-12-07 — Assigned to examiner
  • 2015-12-10 — Final disposition recorded
  • 2015-12-10 — Final disposition recorded
  • 2015-12-10 — Final disposition recorded
  • 2016-06-08 — Office action issued
  • 2016-06-08 — Teas/email correspondence entered
  • 2016-06-08 — Correspondence received in law office
  • 2016-06-28 — Final disposition recorded
  • 2016-06-28 — Final disposition recorded
  • 2016-06-28 — Final disposition recorded
  • 2016-06-30 — Office action issued
  • 2016-07-06 — Assigned to lie
  • 2016-07-13 — Teas/email correspondence entered
  • 2016-07-13 — Correspondence received in law office
  • 2016-07-21 — Approved for pub - principal register
  • 2016-07-25 — Law office publication review completed
  • 2016-08-09 — Withdrawn from pub - og review query
  • 2016-08-14 — Previous allowance count withdrawn
  • 2016-08-18 — Final disposition recorded
  • 2016-08-18 — Final disposition recorded
  • 2016-08-18 — Final disposition recorded
  • 2017-02-17 — Teas amendment of use received
  • 2017-02-17 — Office action issued
  • 2017-02-17 — Correspondence received in law office
  • 2017-02-18 — Amendment to use processing complete
  • 2017-02-18 — Use amendment filed
  • 2017-02-18 — Teas/email correspondence entered
  • 2017-03-07 — Use amendment accepted
  • 2017-03-08 — Notice of acceptance of amendment to allege use e-mailed
  • 2017-03-08 — Office action issued
  • 2017-03-08 — Office action issued
  • 2017-03-08 — Office action issued
  • 2017-06-09 — Teas request for reconsideration received
  • 2017-06-09 — Correspondence received in law office
  • 2017-06-10 — Teas/email correspondence entered
  • 2017-06-28 — Approved for pub - principal register
  • 2017-07-19 — Notification of notice of publication e-mailed
  • 2017-08-08 — Published for opposition
  • 2017-08-08 — Official gazette publication confirmation e-mailed
  • 2017-10-24 — Registered-principal register
  • 2019-01-16 — Automatic update of assignment of ownership
  • 2019-07-12 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-07-12 — Attorney/dom.rep.revoked and/or appointed
  • 2022-04-26 — Attorney/dom.rep.revoked and/or appointed
  • 2022-04-26 — Teas change of owner address received
  • 2022-04-26 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-04-26 — Teas change of correspondence received
  • 2022-04-26 — Applicant/correspondence changes (non-responsive) entered
  • 2022-05-11 — Automatic update of assignment of ownership
  • 2022-10-24 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2024-05-10 — Cancelled sec. 8 (6-yr)
  • 2024-05-10 — Final status recorded

Owner Information

GENERX, INC.
DOVER , DE
MICELLE BIOPHARMA, INC.
RIVIERA BEACH , FL
Sancilio Pharmaceuticals Company, Inc.
Riviera Beach , FL
Sancilio Pharmaceuticals Company, Inc.
Riviera Beach , FL
Sancilio Pharmaceuticals Company, Inc.
Riviera Beach , FL

Correspondent

Mark C. Johnson Johnson Dalal
111 N. Pine Island Road, Suite 105
Plantation, FL 33324
UNITED STATES

Filing Details

Filing Date:
2015-08-24
Status Date:
2024-05-10
Category:
Pharmaceuticals
Filing Year:
2015

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.